Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies

Saprolegniosis is one of the most catastrophic oomycete diseases of freshwater fish caused by the members of the genus Saprolegnia. The disease is responsible for huge economic losses in the aquaculture industry worldwide. Until 2002, Saprolegnia infections were effectively controlled by using malac...

Full description

Bibliographic Details
Main Authors: Dimpal Thakuria, Victoria C. Khangembam, Vinita Pant, Raja Aadil Hussain Bhat, Ritesh Shantilal Tandel, Siva C., Amit Pande, Pramod Kumar Pandey
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.909570/full
_version_ 1818252433078353920
author Dimpal Thakuria
Victoria C. Khangembam
Vinita Pant
Raja Aadil Hussain Bhat
Ritesh Shantilal Tandel
Siva C.
Amit Pande
Pramod Kumar Pandey
author_facet Dimpal Thakuria
Victoria C. Khangembam
Vinita Pant
Raja Aadil Hussain Bhat
Ritesh Shantilal Tandel
Siva C.
Amit Pande
Pramod Kumar Pandey
author_sort Dimpal Thakuria
collection DOAJ
description Saprolegniosis is one of the most catastrophic oomycete diseases of freshwater fish caused by the members of the genus Saprolegnia. The disease is responsible for huge economic losses in the aquaculture industry worldwide. Until 2002, Saprolegnia infections were effectively controlled by using malachite green. However, the drug has been banned for use in aquaculture due to its harmful effect. Therefore, it has become important to find an alternate and safe anti-oomycete agent that is effective against Saprolegnia. In this study, we investigated the anti-oomycete activity of chlorhexidine gluconate (CHG) against Saprolegnia. Before in vitro evaluation, molecular docking was carried out to explore the binding of CHG with vital proteins of Saprolegnia, such as S. parasitica host-targeting protein 1 (SpHtp1), plasma membrane ATPase, and TKL protein kinase. In silico studies revealed that CHG binds with these proteins via hydrogen bonds and hydrophobic interactions. In an in vitro study, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of CHG against S. parasitica were found to be 50 mg/L. Further, it was tested against S. australis, another species of Saprolegnia, and the MIC and MFC were found to be 100 and 200 mg/L, respectively. At 500 mg/L of CHG, there was complete inhibition of the radial growth of Saprolegnia hyphae. In propidium iodide (PI) uptake assay, CHG treated hyphae had bright red fluorescence of PI indicating the disruption of the cell membrane. The results of the present study indicated that CHG could effectively inhibit Saprolegnia and hence can be used for controlling Saprolegniasis in cultured fish.
first_indexed 2024-12-12T16:24:06Z
format Article
id doaj.art-849a4d74167c4ba1a8e5a6c1d87ac644
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-12T16:24:06Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-849a4d74167c4ba1a8e5a6c1d87ac6442022-12-22T00:18:55ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692022-06-01910.3389/fvets.2022.909570909570Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro StudiesDimpal ThakuriaVictoria C. KhangembamVinita PantRaja Aadil Hussain BhatRitesh Shantilal TandelSiva C.Amit PandePramod Kumar PandeySaprolegniosis is one of the most catastrophic oomycete diseases of freshwater fish caused by the members of the genus Saprolegnia. The disease is responsible for huge economic losses in the aquaculture industry worldwide. Until 2002, Saprolegnia infections were effectively controlled by using malachite green. However, the drug has been banned for use in aquaculture due to its harmful effect. Therefore, it has become important to find an alternate and safe anti-oomycete agent that is effective against Saprolegnia. In this study, we investigated the anti-oomycete activity of chlorhexidine gluconate (CHG) against Saprolegnia. Before in vitro evaluation, molecular docking was carried out to explore the binding of CHG with vital proteins of Saprolegnia, such as S. parasitica host-targeting protein 1 (SpHtp1), plasma membrane ATPase, and TKL protein kinase. In silico studies revealed that CHG binds with these proteins via hydrogen bonds and hydrophobic interactions. In an in vitro study, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of CHG against S. parasitica were found to be 50 mg/L. Further, it was tested against S. australis, another species of Saprolegnia, and the MIC and MFC were found to be 100 and 200 mg/L, respectively. At 500 mg/L of CHG, there was complete inhibition of the radial growth of Saprolegnia hyphae. In propidium iodide (PI) uptake assay, CHG treated hyphae had bright red fluorescence of PI indicating the disruption of the cell membrane. The results of the present study indicated that CHG could effectively inhibit Saprolegnia and hence can be used for controlling Saprolegniasis in cultured fish.https://www.frontiersin.org/articles/10.3389/fvets.2022.909570/fullSaprolegniamolecular dockingchlorhexidineanti-oomycete activitymembrane disruption
spellingShingle Dimpal Thakuria
Victoria C. Khangembam
Vinita Pant
Raja Aadil Hussain Bhat
Ritesh Shantilal Tandel
Siva C.
Amit Pande
Pramod Kumar Pandey
Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
Frontiers in Veterinary Science
Saprolegnia
molecular docking
chlorhexidine
anti-oomycete activity
membrane disruption
title Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
title_full Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
title_fullStr Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
title_full_unstemmed Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
title_short Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
title_sort anti oomycete activity of chlorhexidine gluconate molecular docking and in vitro studies
topic Saprolegnia
molecular docking
chlorhexidine
anti-oomycete activity
membrane disruption
url https://www.frontiersin.org/articles/10.3389/fvets.2022.909570/full
work_keys_str_mv AT dimpalthakuria antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT victoriackhangembam antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT vinitapant antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT rajaaadilhussainbhat antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT riteshshantilaltandel antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT sivac antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT amitpande antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies
AT pramodkumarpandey antioomyceteactivityofchlorhexidinegluconatemoleculardockingandinvitrostudies